Collin Van Ryn
Impact in
- Neurology top 2%
- Neuroblastoma Research and Treatments
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
Papers in
- Neurology 14
- Neuroblastoma Research and Treatments 14
-
- Cancer, Hypoxia, and Metabolism 7
- Co-authors
- Julie R. Park (11 shared papers)Wendy B. London (9 shared papers)Arlene Naranjo (11 shared papers)Rochelle Bagatell (6 shared papers)Barry L. Shulkin (5 shared papers)Marguerite T. Parisi (5 shared papers)John M. Maris (4 shared papers)Rajen Mody (3 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Cancer (2 papers)Pediatric Blood & Cancer (2 papers)Clinical Cancer Research (1 paper)Cancer Research (1 paper)
- Partner nations
- United StatesLiberiaSwitzerland
In The Last Decade
Collin Van Ryn
19 papers receiving 637 citations
Peers
Comparison fields: 5 of 63
- Neurology 534
- Cancer Research 202
- Oncology 172
- Genetics 61
- Molecular Biology 279
Countries citing papers authored by Collin Van Ryn
This map shows the geographic impact of Collin Van Ryn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Collin Van Ryn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Collin Van Ryn more than expected).
Fields of papers citing papers by Collin Van Ryn
This network shows the impact of papers produced by Collin Van Ryn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Collin Van Ryn. The network helps show where Collin Van Ryn may publish in the future.
Co-authors
The 25 scholars most cited alongside Collin Van Ryn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 182 | |
| 2 | 2017 | 109 | |
| 3 | 2017 | 95 | |
| 4 | 2017 | 91 | |
| 5 | 2018 | 27 | |
| 6 | 2019 | 26 | |
| 7 | 2017 | 25 | |
| 8 | 2016 | 19 | |
| 9 | 2015 | 15 | |
| 10 | 2022 | 12 | |
| 11 | 2019 | 9 | |
| 12 | 2023 | 9 | |
| 13 | 2016 | 8 | |
| 14 | 2014 | 4 | |
| 15 | 2021 | 3 | |
| 16 | 2014 | 3 | |
| 17 | 2025 | 1 | |
| 18 | Ebola virus persistence in aqueous humor and 12-month outcomes of cataract surgery in survivors of Ebola virus disease | 2019 | 1 |
| 19 | 2017 | 1 | |
| 20 | 2022 | 0 |
About Collin Van Ryn
Collin Van Ryn is a scholar working on Neurology, Cancer Research, Molecular Biology, Infectious Diseases and Oncology, having authored 20 papers that have together received 640 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (14 papers), Cancer, Hypoxia, and Metabolism (7 papers), Cancer therapeutics and mechanisms (5 papers), Viral Infections and Outbreaks Research (4 papers), Lung Cancer Research Studies (4 papers), Neuroendocrine Tumor Research Advances (3 papers), Adrenal and Paraganglionic Tumors (3 papers) and HIV/AIDS Research and Interventions (2 papers). The work is most often cited by research in Neurology (534 citations), Cancer Research (202 citations), Oncology (172 citations), Genetics (61 citations) and Molecular Biology (279 citations). Collin Van Ryn has collaborated with scholars based in United States, Liberia and Switzerland. Frequent co-authors include Julie R. Park, Wendy B. London, Arlene Naranjo, Rochelle Bagatell, Barry L. Shulkin, Marguerite T. Parisi, John M. Maris, Rajen Mody, Paul M. Sondel and Alice L. Yu. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Pediatric Blood & Cancer, Clinical Cancer Research and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.